The Global and United States Veterinary Drug Market Report was published by QY Research recently.
Veterinary Drug Market Analysis and Insights
This report focuses on global and United States Veterinary Drug market, also covers the segmentation data of other regions in regional level and county level.
Veterinary Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Veterinary Drug market will be able to gain the upper hand as they use the report as a powerful resource.
For United States market, this report focuses on the Veterinary Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Access full Report Description, Table of Figure, Chart, Free sample, etc. please click
https://us.qyresearch.com/reports/163778/veterinary-drug
Veterinary Drug Market Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Veterinary Drug Market Segment by Application
Pets
Cattle
Poultry
Swine
Others
The report on the Veterinary Drug market covers the following region analysis:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
The report mentions the prominent market player consisting of:
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Key Objectives of This Report
To study and analyze the global Veterinary Drug consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Veterinary Drug market by identifying its various subsegments.
Focuses on the key global Veterinary Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Veterinary Drug with respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Veterinary Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Key Topics Covered
1 Study Coverage
2 Market by Type
3 Market by Application
4 Global Veterinary Drug Competitor Landscape by Company
5 Global Veterinary Drug Market Size by Region
5.1 Global Veterinary Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Veterinary Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Veterinary Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Veterinary Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Veterinary Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Veterinary Drug Sales in Value by Region: 2017-2022
5.3.2 Global Veterinary Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Veterinary Drug Market Size YoY Growth 2017-2028
6.1.2 North America Veterinary Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Veterinary Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Veterinary Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Veterinary Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Veterinary Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Veterinary Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Veterinary Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Veterinary Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Veterinary Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Corporation Information
7.1.2 Zoetis Description and Business Overview
7.1.3 Zoetis Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Zoetis Veterinary Drug Products Offered
7.1.5 Zoetis Recent Development
7.2 Elanco
7.2.1 Elanco Corporation Information
7.2.2 Elanco Description and Business Overview
7.2.3 Elanco Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Elanco Veterinary Drug Products Offered
7.2.5 Elanco Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporation Information
7.3.2 Boehringer Ingelheim Description and Business Overview
7.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Boehringer Ingelheim Veterinary Drug Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Merck
7.4.1 Merck Corporation Information
7.4.2 Merck Description and Business Overview
7.4.3 Merck Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Merck Veterinary Drug Products Offered
7.4.5 Merck Recent Development
7.5 Virbac
7.5.1 Virbac Corporation Information
7.5.2 Virbac Description and Business Overview
7.5.3 Virbac Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Virbac Veterinary Drug Products Offered
7.5.5 Virbac Recent Development
7.6 Ceva
7.6.1 Ceva Corporation Information
7.6.2 Ceva Description and Business Overview
7.6.3 Ceva Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Ceva Veterinary Drug Products Offered
7.6.5 Ceva Recent Development
7.7 Vetoquinol
7.7.1 Vetoquinol Corporation Information
7.7.2 Vetoquinol Description and Business Overview
7.7.3 Vetoquinol Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Vetoquinol Veterinary Drug Products Offered
7.7.5 Vetoquinol Recent Development
7.8 Dechra
7.8.1 Dechra Corporation Information
7.8.2 Dechra Description and Business Overview
7.8.3 Dechra Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Dechra Veterinary Drug Products Offered
7.8.5 Dechra Recent Development
7.9 Norbrook
7.9.1 Norbrook Corporation Information
7.9.2 Norbrook Description and Business Overview
7.9.3 Norbrook Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Norbrook Veterinary Drug Products Offered
7.9.5 Norbrook Recent Development
7.10 Phibro
7.10.1 Phibro Corporation Information
7.10.2 Phibro Description and Business Overview
7.10.3 Phibro Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Phibro Veterinary Drug Products Offered
7.10.5 Phibro Recent Development
7.11 Huvepharma
7.11.1 Huvepharma Corporation Information
7.11.2 Huvepharma Description and Business Overview
7.11.3 Huvepharma Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Huvepharma Veterinary Drug Products Offered
7.11.5 Huvepharma Recent Development
7.12 Hipra
7.12.1 Hipra Corporation Information
7.12.2 Hipra Description and Business Overview
7.12.3 Hipra Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Hipra Products Offered
7.12.5 Hipra Recent Development
7.13 Ouro Fino Saude
7.13.1 Ouro Fino Saude Corporation Information
7.13.2 Ouro Fino Saude Description and Business Overview
7.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Ouro Fino Saude Products Offered
7.13.5 Ouro Fino Saude Recent Development
7.14 CAHIC
7.14.1 CAHIC Corporation Information
7.14.2 CAHIC Description and Business Overview
7.14.3 CAHIC Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.14.4 CAHIC Products Offered
7.14.5 CAHIC Recent Development
7.15 Orion
7.15.1 Orion Corporation Information
7.15.2 Orion Description and Business Overview
7.15.3 Orion Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Orion Products Offered
7.15.5 Orion Recent Development
7.16 Ringpu Biology
7.16.1 Ringpu Biology Corporation Information
7.16.2 Ringpu Biology Description and Business Overview
7.16.3 Ringpu Biology Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Ringpu Biology Products Offered
7.16.5 Ringpu Biology Recent Development
7.17 Nippon Zenyaku Kogyo
7.17.1 Nippon Zenyaku Kogyo Corporation Information
7.17.2 Nippon Zenyaku Kogyo Description and Business Overview
7.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Nippon Zenyaku Kogyo Products Offered
7.17.5 Nippon Zenyaku Kogyo Recent Development
7.18 Farmavet-Pasteur
7.18.1 Farmavet-Pasteur Corporation Information
7.18.2 Farmavet-Pasteur Description and Business Overview
7.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Farmavet-Pasteur Products Offered
7.18.5 Farmavet-Pasteur Recent Development
Any questions about the report, please click
https://us.qyresearch.com/reports/163778/veterinary-drug
Customization of the Report:
This report can be customized to meet the client’s requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.
Company Profiles:
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com